HSG (HongShan Capital Group), formerly known as Sequoia Capital China, has secured $500.0 million in new funding from investors. This significant capital infusion reinforces the firm's robust financial standing. HSG operates as a leading venture capital and private equity firm, specializing in global investments across the technology, healthcare, and consumer sectors.
Founded in 2005, HSG has established a formidable presence with offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore. The firm currently manages over USD 55 billion in assets across various funds for top institutional investors. Over its nearly two-decade history, HSG has been instrumental in nurturing entrepreneurship and innovation, backing more than 1,500 companies with transformative technologies and high-growth potential.
The firm's investment track record includes over 160 portfolio companies that have successfully listed on public stock exchanges, alongside more than 140 private portfolio companies achieving unicorn status. This new funding round will be strategically deployed to expand HSG's investment capabilities across its diverse funds and sectors, further strengthening its position as a global investment leader. HSG has evolved into a fully integrated investment platform, spanning seed, venture, growth, buyout, infrastructure, and public equities investing.
Looking ahead, HSG remains committed to its mission of helping founders and companies build legendary, enduring businesses while consistently generating superior returns for its limited partners. By leveraging its extensive resources, robust entrepreneurial community, and deep industry expertise, HSG aims to continue fostering innovation and driving growth across its global portfolio.
.png&w=3840&q=75)
